Wellcome Director Dr Jeremy Farrar launched the Astbury BioStructure Laboratory, the results of a £17 million investment in advanced biological research equipment at Leeds University.
Despite huge investment and changes in practices over the years, the rate of drug discovery has not increased and the cost of bringing effective drugs to market remains very high.
Pharmaceutical and Biotechnology innovation at the Astbury Centre for Structural Molecular Biology brings together expertise in a range of physical and biological sciences to pioneer innovative approaches to drug discovery. We work with pharmaceutical and biotechnology companies, as well as supporting industries, to help the sector discover safe new medicines faster.
The scale of the University’s activities and state of the art facilities enable us to operate in a wide variety of areas, through exploitation of outstanding research expertise and engagement with industry. By identifying how our expertise can meet industry needs, we are able to address some of the real problems that slow the progress of getting new drugs to market.
Please contact us for further information or to discuss how we may be able to support your company in providing solutions to your current and future challenges in pharmaceutical development and drug discovery.